a study on Glioblastoma
This study is evaluating the safety and pharmacokinetics of ABT-414 in subjects with glioblastoma multiforme.
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Glioblastoma Multiforme GBM Temozolomide Dacarbazine
Open to people ages 18 years to 99 years
© 2017 The Regents of the University of California